梗阻性肥厚型心肌病室间隔心肌切除术后生存的性别差异
该回顾性单中心研究纳入1961年至2016年接受室间隔心肌切除术的2506例成人梗阻性肥厚型心肌病患者,女性术前年龄更大、症状更重、梗阻更严重。
要点
- 女性室间隔心肌切除术前年龄更大、NYHA III/IV级比例更高、静息左室流出道压差更高。
- 女性未调整中位生存较男性短3.9年,但校正基线变量后性别非独立死亡预测因子。
- 应早期识别女性梗阻性肥厚型心肌病,对药物治疗无效者及时转诊手术。
核心结论
- 女性与男性在室间隔心肌切除术前临床特征存在显著差异,女性年龄更大且症状更重。
- 改善女性梗阻性肥厚型心肌病诊疗应聚焦于早期识别疾病和及时手术转诊。
研究设计与样本
- 回顾性单中心研究,纳入1961年1月至2016年4月接受室间隔心肌切除术的成人患者2506例,其中男性1379例(55.0%)。
- 数据分析时间为2017年12月至2018年12月。
临床怎么用
- 对药物治疗无效的梗阻性肥厚型心肌病患者应及时转诊行室间隔心肌切除术。
- 临床应关注女性患者早期识别,因其术前年龄更大、症状和梗阻更重。
- 评估手术预后时应综合考虑年龄、体重指数、NYHA分级和糖尿病等基线因素。
局限性
- 本研究为回顾性单中心研究,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Recent data indicate that women with hypertrophic cardiomyopathy (HCM) are older and more symptomatic at presentation and have worse clinical outcomes than men. However, to our knowledge, there are no large studies of the association of patient sex with outcomes after surgical myectomy. OBJECTIVE: To analyze preoperative characteristics and overall survival of women and men undergoing septal myectomy for obstructive HCM. DESIGN, SETTING, AND PARTICIPANTS: This retrospective, single-center study included the clinical data of adult patients who underwent septal myectomy from January 1961 through April 2016. Data analysis occurred from December 2017 to December 2018. EXPOSURES: Septal myectomy. MAIN OUTCOMES AND MEASURES: Survival. RESULTS: A total of 2506 adults were included; 1379 patients (55.0%) were men. At the time of surgery, women were older, with median (IQR) age of 59.5 (46.6-68.2) years vs 52.9 (42.9-62.7) years in men (P < .001). Women were more likely to have New York Heart Association class III or IV status at presentation (women, 1023 [90.8%]; men, 1169 [84.8%]; P < .001) and more severe obstructive physiology, as reflected in higher resting left ventricular outflow tract gradients (women, 67.0 [36.0-97.0] mm Hg; men, 50.0 [23.0-81.0] mm Hg; P < .001). Women also had a greater likelihood of having moderate or severe mitral regurgitation (606 [55.2%]) than men (581 [43.1%]; P < .001) and higher right ventricular systolic pressure (women, 36.0 [30.0-46.0] mm Hg; men, 33.0 [28.0-39.0] mm Hg; P < .001). The unadjusted overall survival was lower in women, corresponding to a median 3.9-year shorter survival than men (median [IQR] survival time: women, 18.2 [12.1-27.2] years; men, 22.1 [15.1-32.5] years; P < .001). In a multivariable Cox regression analysis, however, the association between sex and mortality was attenuated and not significant after controlling for other baseline variables (hazard ratio, 0.98 [95% CI, 0.76-1.26]; P = .86). Among the covariates in the model, older age at surgery (adjusted hazard ratio [aHR], 3.09 [95% CI, 2.12-4.52]; P < .001), higher body mass index (aHR, 1.22 [95% CI, 0.90-1.66]; P < .001), greater NYHA class (aHR, 2.31 [95% CI, 1.03-5.15]; P = .04), and presence of diabetes prior to surgery (aHR, 1.57 [95% CI, 1.10-2.24]; P = .01) were each independently associated with increased mortality. Operations performed later in the study period (2013 vs 2004) were associated with decreased mortality (aHR, 0.82 [95% CI, 0.55-1.22]; P = .001). CONCLUSIONS AND RELEVANCE: In this large cohort of surgical patients with obstructive HCM, we observed significant differences at clinical presentation between women and men, in that women were older and more symptomatic. However, after adjustment for important baseline prognostic factors, there was no survival difference after septal myectomy by sex. Improved care of women with obstructive HCM should focus on early identification of disease and prompt surgical referral of appropriate patients who do not respond to medical treatment.
引用
- Meghji Z, Nguyen A, Fatima B, et al. Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. JAMA Cardiol. 2019. PMID: 30810698. doi:10.1001/jamacardio.2019.0084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。